You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 3, September 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Diagnostic Value of an Antinuclear Antibody Test in Clinical Dermatology

N. R. Rowell, MD, MRCP, DCH; J. Swanson Beck, MD, BSc, FRCPGE, MCPath

Arch Dermatol. 1967;96(3):290-295.


Abstract

The incidence, titers, and types of antinuclear antibodies in the sera of 437 selected patients attending a skin clinic have been investigated with an immunofluorescence test.

The connective tissue diseases can be divided into two groups: those disorders, such as lupus erythematosus and systemic sclerosis, in which antinuclear antibodies are frequently found in high titer, and those, such as polyarteritis nodosa, various types of cutaneous vasculitis, and dermatomyositis, in which antinuclear antibodies are usually absent. This division suggests that each group may have a different etiology.

With the unfixed rat liver immunofluorescence test, the presence of high titer (> 1/64) antinuclear antibodies is of value in the differential diagnosis of the connective tissue diseases in patients with overt disease.



Author Affiliations

Leeds, England; Aberdeen, Scotland

From the Skin Department, General Infirmary, Leeds, England (Dr. Rowell), and the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr. Beck).


Footnotes

Accepted for publication May 3, 1967.

Reprint requests to Skin Department, General Infirmary, Leeds, England (Dr. Rowell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Localized scleroderma is an autoimmune disorder
Takehara and Sato
Rheumatology (Oxford) 2005;44:274-279.
ABSTRACT | FULL TEXT  

Antinuclear and Anti-Single-Stranded DNA Antibodies in Morphea and Generalized Morphea
Falanga et al.
Arch Dermatol 1987;123:350-353.
ABSTRACT  

Linear Scleroderma: Clinical Spectrum, Prognosis, and Laboratory Abnormalities
FALANGA et al.
ANN INTERN MED 1986;104:849-857.
ABSTRACT  

High Titers of Antibodies to Single-Stranded DNA in Linear Scleroderma: Vincent Falanga, MD; Thomas A. Medsger, MD; Morris Reichlin, MD
Arch Dermatol 1985;121:345-347.
ABSTRACT  

Localized Scleroderma
Wuthrich et al.
Arch Dermatol 1975;111:98-100.
ABSTRACT  

Lupus Erythematosus
Tuffanelli
Arch Dermatol 1972;106:553-566.
ABSTRACT  

NUCLEAR IMMUNOFLUORESCENT PATTERNS
Burnham et al.
Arch Dermatol 1969;99:364-365.
ABSTRACT  

Bullous Pemphigoid Associated With Systemic Lupus Erythematosus
Jordon et al.
Arch Dermatol 1969;99:17-25.
ABSTRACT  

COMMENTS ON ANTINUCLEAR ANTIBODIES
Burnham et al.
Arch Dermatol 1968;97:99-100.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.